Geographic Variation in Admission for Opioid Tx Programs

This article originally appeared here.
Share this content:
Geographic Variation in Admission for Opioid Tx Programs
Geographic Variation in Admission for Opioid Tx Programs

TUESDAY, April 4, 2017 (HealthDay News) -- There is geographic variation in treatment admissions among opioid treatment programs that accept Medicaid, according to a study published online March 27 in Health Services Research.

Amanda J. Abraham, Ph.D., from the University of Georgia in Athens, and colleagues used data from the 2012 National Survey of Substance Abuse Treatment Services to examine county-level geographic variation in treatment admissions among opioid treatment programs that accept Medicaid.

The researchers identified several clusters of counties that had higher-than-average rates of opioid use disorder (OUD) and lower-than-average treatment admissions among outpatient treatment programs (OTPs). The clusters were concentrated in the Southeast and included Arkansas, Kentucky, Louisiana, Mississippi, and Tennessee.

"Medicaid enrollees in areas in the Southeast have the largest gaps between county-level OUD rates and estimated county-level capacity for treatment, as measured by county-level total treatment admissions among OTPs that accept Medicaid," the authors write. "Policy makers should consider strategies to increase the availability of OTPs with the capacity to serve Medicaid enrollees."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »